Assessment of Music Experiences in Navigating Depression

Not Applicable

Completed

• Conditions: Depression

• Registration Number: NCT06924892
• Lead Sponsor: Icahn School of Medicine at Mount Sinai

Brief Summary

The study team sought to scientifically investigate strategic subsets of depressed individuals or people prone to or at-risk of depression through music experiences of individual, group, and blended supported contexts. Meetings with the study multi-disciplinary team, included member of the Carnegie Hall Weill Music Institute and University affiliates, where the study team gathered quantitative and qualitative data in individual and group forums, measuring disease process and levels of participation. Through tabulation of participatory options with standardized depression and resilience measurements, the study team studied how live music could alter depressive symptoms over time and/or change negative influencers of mood, shift quality of life, and lead toward possibly enhanced disease trajectory outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-05
• Status Verified: 2025-03
• Primary Completion: 2025-03-24
• Study Completion: 2025-03-30
• Study First Submitted: 2025-04-04
• Study First Submitted QC: 2025-04-04
• Last Update Submitted: 2025-04-04
• Study First Posted: 2025-04-11
• Last Update Posted: 2025-04-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

• Participants between the ages of 8-70 years with a clinical diagnosis of Major Depressive Disorder (MOD) who met the DSM-5 (2013) criteria for a Major Depressive Episode, and/or who identify themselves, or are identified by family, or referring clinicians as depressed, or are prone to depression
• Depressive episodes and/or showing symptoms of mild to moderate depression intensity
• Self-reported satisfactory bilateral hearing
• English or Spanish language fluency sufficient to complete the interviews and questionnaires

Exclusion Criteria

• Axis I diagnosis, aside from MOD, considered the primary diagnosis
• Bipolar Disorder Type I or II,
• Axis II diagnosis such as antisocial or borderline.
• Arrhythmia,
• Pacemaker
• Prolapsed vertebral disc, and
• Recent back or neck injuries.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Connor-Davidson Resilience Scale (CD-RISC)	end of study at 3 months	The Connor-Davidson Resilience Scale (CD-RISC) measures inherent resiliency. The 10-item instrument has high internal consistency. Each item consists of a 5-point Likert scale (scored from zero to four). Ranging from 0-40 with higher scores reflecting greater perceived resilience.
The Beck Depression Inventory Second Edition (BDI-II) Score	end of study at 3 months	The Beck Depression Inventory Second Edition (BDI-II) is a multiple-choice self-report inventory that assesses severity of depression. The BDI-II contains 21 items on a 4-point scale from 0 (symptom absent) to 3 (severe symptoms). The minimum score is 0 and the maximum score is 63, with a higher score indicating more severe depressive symptoms.
Child Depression Inventory	end of study at 3 months	The total score range 0 to 54 which is converted to a T-Score, higher score indicates more symptoms.

Trial Locations

Locations (1)

Mount Sinai Union Square; 🇺🇸 NY, New York, United States